Cytel Inc., an advanced analytics leader with over thirty years of experience providing sophisticated quantitative insights to executive decision-makers in the lifesciences.
Cytel employs a range of data science tools from biostatistics to machine learning to help executives in the life-sciences to make confident decisions powered by data. We are probably best known for being leaders in the field of adaptive clinical trial design, a subset of trial design that uses interim looks to enhance the patient safety and commercial value of pharmaceutical products. We also have specialists in Bayesian statistics, real world evidence, artificial intelligence, health economics, and a number of other research fields to ensure that academic and scientific findings can have impact on industry quickly and seamlessly.
www.cytel.com
Cytel employs a range of data science tools from biostatistics to machine learning to help executives in the life-sciences to make confident decisions powered by data. We are probably best known for being leaders in the field of adaptive clinical trial design, a subset of trial design that uses interim looks to enhance the patient safety and commercial value of pharmaceutical products. We also have specialists in Bayesian statistics, real world evidence, artificial intelligence, health economics, and a number of other research fields to ensure that academic and scientific findings can have impact on industry quickly and seamlessly.
www.cytel.com
Location: United States, Massachusetts, Waltham
Employees: 1001-5000
Phone: +1 617-661-2011
Founded date: 1987
Investors 2
| Date | Name | Website |
| - | Autonomy V... | autonomyve... |
| - | Nordic Cap... | nordiccapi... |
Mentions in press and media 6
| Date | Title | Description |
| 10.07.2023 | Cytel Acquires stève consultants | Cytel, a Waltham, MA-based provider of quantitative insights and health data analytics to leaders in life sciences, acquired stève consultants, an Oullins, France-based company which specializes in market access, real-world (RWE), and healt... |
| 10.07.2023 | Cytel Acquires French Group stève consultants to Further Expand Value Evidence and Real-World Analytics Capabilities | Cytel provider of quantitative insights and health data analytics to leaders in life sciences, has acquired stève consultants, specialists in market access, real-world (RWE), and health economics and outcomes research (HEOR). The acquisitio... |
| 07.03.2022 | New Study Finds Conversion Therapy, and its Associated Harms, Cost the U.S. an Estimated $9.23 Billion Annually | This alarming study illustrates that subjecting LGBTQ young people to conversion therapy continues to have deep and detrimental costs from both a humanistic and economic standpoint. WASHINGTON (PRWEB) March 07, 2022 Research scientists at T... |
| 21.12.2020 | Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel | Nordic Capital and Astorg today announced an agreement to jointly acquire Cytel Inc. (“Cytel”), from New Mountain Capital. Cytel is one of the largest providers of statistical software and advanced analytics for clinical trial design and bi... |
| 02.11.2017 | Term Sheet — Thursday, November 2 | SKY HIGH Good morning, Term Sheet readers. Paid Content What you need to know about growing cyberattacks From ExtraHop HOLD THE CHAMPAGNE: HelloFresh, the Germany-based meal kit company, made its market debut, and it wasn’t horrible. In fac... |
| 02.07.2008 | ClinPhone and Cytel – A New Partnership Delivering Complete Solutions for Adaptive Clinical Trials | (Nottingham, UK and Cambridge, USA 2 July 2008). ClinPhone, the world’s largest Clinical Technology Organization (CTO) and Cytel Inc., leading statistical experts in adaptive clinical trials, announced today a unique partnership that unites... |